James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

The new analysis was presented at the AHA Scientific Sessions 2022 conference and simultaneously published in the Journal of the American College of Cardiology.

Join us for an expert panel webinar on the just-released PRECISE Trial 1-year results that showed using coronary CTA with FFRCT Analysis to evaluate suspected coronary artery disease offers more accurate non-invasive diagnosis, fewer unnecessary tests and higher confidence among physicians in identifying patients needing treatment. The data demonstrates AHA/ACC Chest Pain Guideline-directed CCTA plus FFRCT Precision Pathway is superior to traditional testing. Watch now! 

Among women, on the other hand, drinking coffee may actual reduce the risk of CHD. The full meta-analysis, based on data from 32 different studies, was published in the American Journal of Cardiology.

American College of Cardiology President Edward Fry, MD, spoke about recent Medicare cuts at the American Heart Association Scientific Sessions conference in Chicago. 

Researchers examined data from more than 1,800 CLTI patients, comparing bypass surgery with minimally invasive treatment options such as angioplasty and stenting.

"We expected to see a significant improvement in outcomes for patients with severe or rapidly progressing cardiogenic shock who underwent early ECMO treatment," one specialist said. 

The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 

The new guidance, published in the Journal of the American College of Cardiology, covers a variety of topics, including thoracic aortic disease, peripheral artery disease, shared decision-making and cardiac imaging.